Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | PTPRF | P10586 | 6/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.35 |
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26225071 | 1.00 | LIMK1 (0.37) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL25458408 | 1.00 | LIMK1 (0.37) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26762620 | 0.99 | LIMK1 (0.38) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26214558 | 0.99 | LIMK1 (0.38) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26225117 | 0.98 | PIM1 (0.37) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26763211 | 0.97 | PIM1 (0.36) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26221650 | 0.97 | PIM1 (0.36) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL24929386 | 0.95 | ALOX5 (0.37) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26228634 | 0.94 | ALOX5 (0.36) | LIMK1ALOX5PIM1CSNK2A2CSNK2B | |
| SCHEMBL26228691 | 0.94 | ALOX5 (0.36) | LIMK1ALOX5PIM1CSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357209-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-20230357209-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-20230157151-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230157151-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357209-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP1B1, ODC1 | LIMK1 270/4885ALOX5 309/4885PIM1 1206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.